EMEA-001847-PIP01-15 - paediatric investigation plan

Pexiganan (acetate)

Key facts

• Active Substance:
  Pexiganan (acetate)
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/0032/2016
• PIP number:
  EMEA-001847-PIP01-15
• Pharmaceutical form(s):
  Cream
• Condition(s) / indication(s):
  Treatment of diabetic foot ulcer
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  29/01/2016

Decision

P/0032/2016: EMA decision of 29 January 2016 on the granting of a product specific waiver for pexiganan (acetate) (EMEA-001847-PIP01-15)

AdoptedReference Number: EMA/864347/2015